

HY-141521 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-141521
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/nx-13.htmlDescription
NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohns disease and ulcerative colitis.







